NCT03542526

Brief Summary

To review the accuracy of electrocardiography in screening for left ventricular hypertrophy in patients with hypertension.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
73

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 31, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

January 1, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

May 31, 2018

Status Verified

May 1, 2018

Enrollment Period

2 years

First QC Date

March 27, 2018

Last Update Submit

May 20, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • minimize complicate of hypertension

    screening with hypertensive patient

    1 years

Interventions

12 lead ecg ambulatory blood prussre

Also known as: blood measuring device

ambulatory blood pressure to measure blood pressure

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All eligible patients attending the Hypertension outpatient clinic over two year duration starting from November 2018, will be consecutively enrolled

You may qualify if:

  • Patients ranging from 20t o 80 years attending the hypertension outpatient clinic for ambulatory blood pressure measurement will be consecutively enrolled

You may not qualify if:

  • Patients with ischemic heart disease.
  • Patients with advanced respiratory, renal, or hepatic disease
  • Patients with uninterpretable ECG or ABPM recordings

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AssiutU

Asyut, Egypt

RECRUITING

Related Publications (2)

  • Jain A, Tandri H, Dalal D, Chahal H, Soliman EZ, Prineas RJ, Folsom AR, Lima JA, Bluemke DA. Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2010 Apr;159(4):652-8. doi: 10.1016/j.ahj.2009.12.035.

    PMID: 20362725BACKGROUND
  • Pewsner D, Juni P, Egger M, Battaglia M, Sundstrom J, Bachmann LM. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ. 2007 Oct 6;335(7622):711. doi: 10.1136/bmj.39276.636354.AE. Epub 2007 Aug 28.

    PMID: 17726091BACKGROUND

Related Links

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Central Study Contacts

Yehia t Keshk, professor

CONTACT

Tarek a nagib, lecturer

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
cardiology resident, principle investigator

Study Record Dates

First Submitted

March 27, 2018

First Posted

May 31, 2018

Study Start

January 1, 2019

Primary Completion

December 31, 2020

Study Completion

December 31, 2022

Last Updated

May 31, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

to maintain the privacy of the protocol

Locations